Partnerships & Manufacturing · Institutional Framework

Scale Alliances

Three ways to collaborate: NM-mRNA product systems, translational research and EPITIDE™ distribution. Share your goal and discuss applications, scope and opportunities directly.

Choose the route that matches your goal; then share your organization, context and scope in the form. The same entry point directs each request to the appropriate conversation.

— 01Collaboration pathways

PATH-01

NM-mRNA · Development & licensing

Explore NM-mRNA applications, development opportunities and collaboration models. The conversation starts with the partner's technical goal; details are aligned with the partnership scope.

Start this conversation →

Steps

01Define the problem, intended application, payload, and discussion scope.
02Align stakeholders and confidentiality needs; an NDA only where appropriate and mutually agreed.
03Align shareable technical materials and the application's critical attributes.
04Develop a proposed plan for characterization, qualification, transfer, and decision milestones, subject to feasibility.

Requirements for review

Identified organization and technical team; intended application; relevant quality/regulatory requirements and development capabilities.

Availability and terms

Materials and collaboration terms are reviewed individually, according to availability, confidentiality and agreed scope.

PATH-02

Research · Characterization & studies

A route to shape studies, methods and scientific questions with research teams. Scope, materials and governance are aligned with participants.

Start this conversation →

Steps

01Frame the question, hypothesis, and characterization needs.
02Specify methods, materials/samples, endpoints, controls, and comparability criteria.
03Agree data governance, confidentiality, publication, and intellectual property before work begins.
04Assess resources, indicative timing, and any ethics/regulatory approvals that may be required.

Requirements for review

A bounded technical proposal, relevant capabilities/methods, identified leads, and a documented approach to data and intellectual property.

Availability and terms

Access to materials, data and resources is addressed according to the collaboration design and applicable agreements.

PATH-03

EPITIDE™ · Commercial distribution

A commercial route separate from NM-mRNA and research initiatives. An expression of interest starts a review of the channel, territory, availability and requirements for commercialization.

Start this conversation →

Steps

01Identify the proposed channel, territory, audience, and distribution model.
02Confirm commercial availability, applicable regulatory status, current composition/labeling, and verifiable documentation.
03Assess channel qualification, traceability, responsible communications, and complaint handling requirements.
04Align logistics, commercial terms, and responsibilities only after assessment and formal agreement.

Requirements for review

Organization and channel details, intended countries/territories, distribution capabilities, and local regulatory context.

Availability and terms

Territory, availability, documentation, regulatory requirements and commercial terms are reviewed before each agreement. An initial inquiry is not an order or commercial offer.

Institutional request

Request a conversation or document access

Use the form to indicate whether your inquiry concerns NM-mRNA licensing/development, translational research, or partnership—describe EPITIDE™ distribution in the scope field. Include your organization, territory, objective, and requested materials for initial review.

Private technical discussion

Tell us what you are interested in so we can connect you with the right contact. Technical materials and specific information may be shared according to scope, availability and confidentiality.

01 / Share context

Organization, area of interest and technical goal.

02 / Review scope

The team identifies the appropriate contact and any confidentiality needs.

03 / Indicate next step

A response follows through the email provided; materials depend on scope and availability.

Institutional diligence package

Share the technical context so we can send the appropriate documentation. This form opens a partnership, research or licensing conversation — not an EPITIDE™ purchase request.